Ambit Biosciences
Biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer, inflammatory disease, and other indications
Biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer, inflammatory disease, and other indications
Gene therapy company focused on the research and development of novel therapeutics for patients with unmet medical needs utilizing AGTC's proprietary, non-pathogenic adeno-associated virus (AAV) delivery system
Biopharmaceutical company dedicated to the discovery and development of innovative medicines to treat inflammatory and metabolic diseases
Spine-focused company developing a biological medical device for enhancement of cervical spine fusion
Drug development company focused on epigenetics (with targets in oncology and immune disorders) and infectious disease utilizing a proprietary self-assembling dimeric chemistry platform
Biopharmaceutical company that focuses on arginase inhibition to promote endothelial function
Biopharmaceutical company focused on the development of antibody therapeutics for the treatment of life-threatening diseases
Biopharmaceutical company that develops drugs to treat pain, inflammation, cardiovascular, and other diseases using its expertise in novel ion channels
Biopharmaceutical firm focused on the development of innovative drug candidates to address significant diseases of the eye, with a major focus on glaucoma
NeuProtect Pty Ltd is a life sciences start-up company based in Melbourne, Australia. NeuProtect is developing proprietary cardioprotectant and neuroprotectant small molecules to reduce tissue damage following a heart attack or stroke
Biotechnology company focused on developing therapeutics based on unique immune cells called natural killer T (NKT) cells
Biotechnology company developing novel antibody therapeutic for rheumatoid arthritis and other indications
Biotechnology company developing novel, proprietary vaccines for infectious diseases
Biopharmaceutical company committed to the development and commercialization of novel medicines for the treatment of cancer, respiratory, and autoimmune diseases
Biotechnology company that focuses on antibody engineering to significantly improve antibody half-life, immune-regulatory function and potency